About Synartro
Synartro is a startup. Brouky classifies it under Healthcare & Life Sciences.
Synartro is developing a treatment for knee osteoarthritis that combines two established drugs to provide an effective and safe alternative to current therapies.
Explore Synartro's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.